Sort
16,300 grants matching “fatty liver disease”
Genetic and physiological causes of inherited Vascular and Metabolic Diseases
$409,613Arya Mani · Yale University · R01 · FY2012 · HL
The genetics and pathophysiology of impaired Wnt signaling in metabolic syndrome
$409,613Arya Mani · Yale University · R01 · FY2012 · HL
Regulation of hepatic glucose production by Kruppel-like factor 15.
$409,605Susan Jessica Gray · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · DK
Mechanisms regulating lipoprotein secretion and lipid metabolism
$409,599Hongmin Ni · University Of Kansas Medical Center · R01 · FY2023 · DK
Project 4: Interrogating and harnessing age-related IFN signaling and innate immunity in HCC prevention and therapy
$409,560Gen-Sheng Feng · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2024 · AG
Post-translational regulation of hepatic uptake transporters in health and disease
$409,391Bruno Hagenbuch · University Of Kansas Medical Center · R01 · FY2024 · GM
The role of non-nutritive sweeteners-microbiome interactions in the pathogenesis of metabolic syndrome
$409,375Jotham Suez · Johns Hopkins University · DP5 · FY2024 · OD
The role of non-nutritive sweeteners-microbiome interactions in the pathogenesis of metabolic syndrome
$409,375Jotham Suez · Johns Hopkins University · DP5 · FY2023 · OD
The role of non-nutritive sweeteners-microbiome interactions in the pathogenesis of metabolic syndrome
$409,375Jotham Suez · Johns Hopkins University · DP5 · FY2021 · OD
The role of non-nutritive sweeteners-microbiome interactions in the pathogenesis of metabolic syndrome
$409,375Jotham Suez · Johns Hopkins University · DP5 · FY2020 · OD
The role of non-nutritive sweeteners-microbiome interactions in the pathogenesis of metabolic syndrome
$409,375Jotham Suez · Johns Hopkins University · DP5 · FY2022 · OD
Novel roles of hepatic fatty acid oxidation
$409,375Michael J. Wolfgang · Johns Hopkins University · R56 · FY2024 · DK
MIF in progression and treatment of ALD
$409,169Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2014 · AA
MIF in progression and treatment of ALD
$409,168Laura E. Nagy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2015 · AA
Balance between HNF4a isoforms in the carbohydrate-lipid metabolic switch
$409,162Frances M Sladek · University Of California Riverside · R01 · FY2023 · DK
C/EBP beta Peptides for the Treatment of Hepatic Fibrosis
$409,097Martina Buck · Veterans Medical Research Fdn/San Diego · RC1 · FY2010 · DK
The Role of Cardiolipin In The TCA Cycle: Implications For Barth Syndrome
$409,043Miriam L Greenberg · Wayne State University · R01 · FY2016 · HL
Regulation of Liver Growth and Function
$408,981Scot R Kimball · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2016 · DK
Regulation of Liver Growth and Function
$408,981Scot R Kimball · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2018 · DK
Regulation of Liver Growth and Function
$408,981Scot R Kimball · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2017 · DK
Regulation of Liver Growth and Function
$408,981Leonard S Jefferson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2015 · DK
Epidemiology of Ultrasound-Defined NAFLD in the General U.S. Population
$408,978Jeanne M Clark · Johns Hopkins University · R01 · FY2009 · DK
Hydrolytic enzymes in the metabolism of toxins
$408,939Bruce D Hammock · University Of California At Davis · R01 · FY2014 · ES
DETECTION AND MODELS OF TOXICANT EXPOSURE
$408,869Robert H Tukey · University Of California, San Diego · P42 · FY2020 · ES
Combining experiments of man and nature to target human insulin resistance
$408,826Amit Majithia · University Of California, San Diego · R01 · FY2024 · DK